Geographical variations in the prevalence of COPD in Spain: Relationship to smoking, death rates and other determining factors;Diferencias geográficas en la prevalencia de EPOC en España: Relación con hábito tabáquico, tasas de mortalidad y otros determinantes

Archivos de Bronconeumologia

Volumn 46, Issue 10, 2010, Pages 522-530

  Soriano, Joan B ^a   Miravitlles, Marc ^b   Borderías, Luis ^c   Duran Tauleria, Enric ^d   García Río, Francisco ^e   Martínez, Jaime ^f   Montemayor, Teodoro ^g   Muñoz, Luis ^h   Piñeiro, Luis ⁱ   Sánchez, Guadalupe ^j   Serra, Joan ^k   Soler Cataluña, Juan José ^l   Torres, Antoni ^m   Luis Viejo, Jose ⁿ   Sobradillo Peña, Víctor ^o   Ancochea, Julio ^p  

^a Fundación Caubet   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL SAN JORGE   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^h HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁱ HOSPITAL XERAL CÍES   (Spain)

^j GLAXOSMITHKLINE   (Spain)

^k HOSPITAL GENERAL DE VIC   (Spain)

^l HOSPITAL GENERAL DE REQUENA   (Spain)

^m UNIVERSITY OF BARCELONA   (Spain)

ⁿ HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^o HOSPITAL DE CRUCES   (Spain)

^p HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

more..

Author keywords

COPD; EPI SCAN; Smoking; Spain; Variation

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; SMOKING; SPAIN; SPIROMETRY; AGE DISTRIBUTION; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; ECOSYSTEM HEALTH; GEOGRAPHICAL VARIATION (SPECIES); MIDDLE AGED; MORTALITY RATE; THERAPY DELAY;

EID: 77957750081     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S1579-2129(11)60005-0     Document Type: Article

References (26)

1. World Health Organization. WHO REPORT on the global TOBACCO epidemic, 2009. Implementing smoke-free environments. WHO Library Cataloguing-in-Publication Data ISBN 978 92 4 156391 8 (NLM classification: WM 290)© World Health Organization 2009.
2. Encuesta Europea de Salud en España. Avance de resultados del segundo y tercer trimestre de 2009 (a 29 de Diciembre de 2009) http://www.ine.es/prensa/np582.pdf.
3. Miravitlles M., Soriano J.B., García-Río R., Muñoz L., Durán-Tauleria E., Sánchez G., et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009, 64:863-868.
4. Sobradillo-Peña V., Miravitlles M., Gabriel R., Jiménez-Ruiz C.A., Villasante C., Masa J.F., et al. Geographical variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicentre epidemiological study. Chest 2000, 118:981-989.
5. Miravitlles M., Ferrer M., Pont A., Viejo J.L., Masa J.F., Gabriel R., et al. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med. 2005, 99:985-995.
6. Soriano JB, Ancochea J, Miravitlles M, García-Río F, Duran E, Muñoz L, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur Respir J 2010 (en prensa).
7. Brody H., Rip M.R., Vinten-Johansen P., Paneth N., Rachman S. Map-making and myth-making in Broad Street: the London cholera epidemic, 1854. Lancet 2000, 356:64-68.
8. Rezaeian M., Dunn G., St Leger S., Appleby L. Geographical epidemiology, spatial analysis and geographical information systems: a multidisciplinary glossary. J Epidemiol Community Health 2007, 61:98-102.
9. La Estrategia en EPOC del Sistema Nacional de Salud. Ministerio de Salud y Políticas Sociales. Madrid, 2009.
10. Menezes A.M., Pérez-Padilla R., Jardim J.R., Muiño A., López M.V., Valdivia G., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005, 366:1875-1881. PLATINO Team.
11. Buist A.S., McBurnie M.A., Vollmer W.M., Gillespie S., Burney P., Mannino D.M., et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007, 370:741-750. BOLD Collaborative Research Group.
12. Ancochea J., Badiola C., Durán-Tauleria E., García Río F., Miravitlles M., Muñoz L., Sobradillo V., et al. Estudio EPI-SCAN: resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años en España. Arch Bronconeumol 2009, 45:41-47.
13. Minette A., Aresini G., Sanna-Randaccio F., Seaton A., Smidt U., Teculescu D. Cuestionario CECA para el estudio de los síntomas respiratorios, 1987 1988, Comisión de las Comunidades Europeas. Luxemburgo 3.a ed.
14. Miller M.R., Hankison J., Brusasco V., Burgos R., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
15. Quanjer Ph., Tammeling G., Cotes J., Pedersen O., Peslin R., Yernault J. Lung volumes and forced ventilatory flows. Eur Respir J 1993, 1(Suppl. 16):5-40. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.
16. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946. ATS/ERS Task Force, [www.ersnet.org Date last updated: December 2007].
17. Centro Nacional de Epidemiología. Servidor Raziel. Disponible en Instituto de Salud Carlos III; 2010. [consultado 20/4/2010]. http://193.146.50.130/raziel.php.
18. Tashkin D.P., Celli B., Decramer M., Liu D., Burkhart D., Cassino C., et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008, 31:742-750.
19. Soriano J.B., Miravitlles M. Datos epidemiológicos de EPOC en España. Arch Bronconeumol 2007, 43(Supl 1):2-9.
20. Zhang Y, Baicker K, Newhouse JP. Geographic Variation in Medicare Drug Spending. N Engl J Med 2010; 10.1056/nejmp1004872:1-5.
21. [No authors listed]. Health effects of outdoor air pollution. Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society. Am J Respir Crit Care Med 1996;153:3-50.
22. Allen N.B., Holford T.R., Bracken M.B., Goldstein L.B., Howard G., Wang Y., et al. Geographic variation in one-year recurrent ischemic stroke rates for elderly medicare beneficiaries in the USA. Neuroepidemiology 2010, 34:123-129.
23. Best N., Hansell A.L. Geographic variations in risk: adjusting for unmeasured confounders through joint modeling of multiple diseases. Epidemiology 2009, 20:400-410.
24. Pellicer C., Soler-Cataluña J.J., Andreu A.L., Bueso J. Calidad del diagnóstico de la enfermedad pulmonar obstructiva crónica en el ámbito hospitalario. Arch Bronconeumol 2010, 46:64-69.
25. Soler-Cataluña J.J., Calle M., Cosío B.G., Marín J.M., Monsó E., Alfageme I. Estándares de calidad en EPOC. Arch Bronconeumol 2009, 45:196-203. Comité de Calidad Asistencial de la SEPAR; Area de Trabajo EPOC de la SEPAR, Epub 2009 Mar 21. Errata en: Arch Bronconeumol. 2009 Jul;45(7):361-2.
26. Soriano J.B., Zielinski J., Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009, 374:721-732.